logo
Nearby Sculptor galaxy revealed in ultra-detail

Nearby Sculptor galaxy revealed in ultra-detail

The Advertiser4 days ago

The Sculptor galaxy is similar in many respects to our Milky Way. It is about the same size and mass, with a similar spiral structure. But while it is impossible to get a full view of the Milky Way from the vantage point of Earth because we are inside the galaxy, Sculptor is perfectly positioned for a good look.
Astronomers have done just that, releasing an ultra-detailed image of the Sculptor galaxy on Wednesday obtained with 50 hours of observations using one of the world's biggest telescopes, the European Southern Observatory's Chile-based Very Large Telescope.
The image shows Sculptor, also called NGC 253, in around 4000 different colours, each corresponding to a specific wavelength in the optical spectrum.
Because various galactic components emit light differently across the spectrum, the observations are providing information at unprecedented detail on the inner workings of an entire galaxy, from star formation to the motion of interstellar gas on large scales. Conventional images in astronomy offer only a handful of colours, providing less information.
The researchers used the telescope's Multi Unit Spectroscopic Explorer, or MUSE, instrument.
"NGC 253 is close enough that we can observe it in remarkable detail with MUSE, yet far enough that we can still see the entire galaxy in a single field of view," said astronomer Enrico Congiu, a fellow at the European Southern Observatory in Santiago, and lead author of research being published in the journal Astronomy & Astrophysics.
"That's why NGC 253 is such a perfect target: it acts as a bridge between the ultra-detailed studies of the Milky Way and the large-scale studies of more distant galaxies. It gives us a rare opportunity to connect the small-scale physics with the big-picture view."
Sculptor is about 11 million light-years from Earth, making it one of the closest big galaxies to the Milky Way. A light-year is the distance light travels in a year, 9.5 trillion km.
Like the Milky Way, it is a barred spiral galaxy, meaning it has an elongated structure extending from its nucleus, with spiral arms extending from the ends of the bar. Its diameter of about 88,000 light-years is similar to the Milky Way's, as is its total mass. One major difference is Sculptor's rate of new star formation, estimated to be two to three times greater than that of the Milky Way.
Nearly 30 per cent of this star formation is happening near the galaxy's nucleus in what is called a starburst region, as revealed in colourful emissions shown in the new image.
The observations have given information on a wide range of properties such as the motion, age and chemical composition of stars and the movement of interstellar gas, an important component of any galaxy.
"Since the light from stars is typically bluer if the stars are young or redder if the stars are old, having thousands of colours lets us learn a lot about what stars and populations of stars exist in the galaxy," said astronomer Kathryn Kreckel of Heidelberg University in Germany, a study co-author.
"Similarly for the gas, it glows in specific bright emission lines at very specific colours, and tells us about the different elements that exist in the gas, and what is causing it to glow," Kreckel said.
The initial research being published from the observations involves planetary nebulae, which are luminous clouds of gas and dust expelled by certain dying stars. Despite their name, they have nothing to do with planets. These nebulae can help astronomers measure the precise distances of faraway galaxies.
The researchers marveled at the scientific and aesthetic value of the new view of Sculptor.
"I personally find these images amazing," Congiu said.
"What amazes me the most is that every time I look at them, I notice something new - another nebula, a splash of unexpected colour or some subtle structure that hints at the incredible physics behind it all."
The Sculptor galaxy is similar in many respects to our Milky Way. It is about the same size and mass, with a similar spiral structure. But while it is impossible to get a full view of the Milky Way from the vantage point of Earth because we are inside the galaxy, Sculptor is perfectly positioned for a good look.
Astronomers have done just that, releasing an ultra-detailed image of the Sculptor galaxy on Wednesday obtained with 50 hours of observations using one of the world's biggest telescopes, the European Southern Observatory's Chile-based Very Large Telescope.
The image shows Sculptor, also called NGC 253, in around 4000 different colours, each corresponding to a specific wavelength in the optical spectrum.
Because various galactic components emit light differently across the spectrum, the observations are providing information at unprecedented detail on the inner workings of an entire galaxy, from star formation to the motion of interstellar gas on large scales. Conventional images in astronomy offer only a handful of colours, providing less information.
The researchers used the telescope's Multi Unit Spectroscopic Explorer, or MUSE, instrument.
"NGC 253 is close enough that we can observe it in remarkable detail with MUSE, yet far enough that we can still see the entire galaxy in a single field of view," said astronomer Enrico Congiu, a fellow at the European Southern Observatory in Santiago, and lead author of research being published in the journal Astronomy & Astrophysics.
"That's why NGC 253 is such a perfect target: it acts as a bridge between the ultra-detailed studies of the Milky Way and the large-scale studies of more distant galaxies. It gives us a rare opportunity to connect the small-scale physics with the big-picture view."
Sculptor is about 11 million light-years from Earth, making it one of the closest big galaxies to the Milky Way. A light-year is the distance light travels in a year, 9.5 trillion km.
Like the Milky Way, it is a barred spiral galaxy, meaning it has an elongated structure extending from its nucleus, with spiral arms extending from the ends of the bar. Its diameter of about 88,000 light-years is similar to the Milky Way's, as is its total mass. One major difference is Sculptor's rate of new star formation, estimated to be two to three times greater than that of the Milky Way.
Nearly 30 per cent of this star formation is happening near the galaxy's nucleus in what is called a starburst region, as revealed in colourful emissions shown in the new image.
The observations have given information on a wide range of properties such as the motion, age and chemical composition of stars and the movement of interstellar gas, an important component of any galaxy.
"Since the light from stars is typically bluer if the stars are young or redder if the stars are old, having thousands of colours lets us learn a lot about what stars and populations of stars exist in the galaxy," said astronomer Kathryn Kreckel of Heidelberg University in Germany, a study co-author.
"Similarly for the gas, it glows in specific bright emission lines at very specific colours, and tells us about the different elements that exist in the gas, and what is causing it to glow," Kreckel said.
The initial research being published from the observations involves planetary nebulae, which are luminous clouds of gas and dust expelled by certain dying stars. Despite their name, they have nothing to do with planets. These nebulae can help astronomers measure the precise distances of faraway galaxies.
The researchers marveled at the scientific and aesthetic value of the new view of Sculptor.
"I personally find these images amazing," Congiu said.
"What amazes me the most is that every time I look at them, I notice something new - another nebula, a splash of unexpected colour or some subtle structure that hints at the incredible physics behind it all."
The Sculptor galaxy is similar in many respects to our Milky Way. It is about the same size and mass, with a similar spiral structure. But while it is impossible to get a full view of the Milky Way from the vantage point of Earth because we are inside the galaxy, Sculptor is perfectly positioned for a good look.
Astronomers have done just that, releasing an ultra-detailed image of the Sculptor galaxy on Wednesday obtained with 50 hours of observations using one of the world's biggest telescopes, the European Southern Observatory's Chile-based Very Large Telescope.
The image shows Sculptor, also called NGC 253, in around 4000 different colours, each corresponding to a specific wavelength in the optical spectrum.
Because various galactic components emit light differently across the spectrum, the observations are providing information at unprecedented detail on the inner workings of an entire galaxy, from star formation to the motion of interstellar gas on large scales. Conventional images in astronomy offer only a handful of colours, providing less information.
The researchers used the telescope's Multi Unit Spectroscopic Explorer, or MUSE, instrument.
"NGC 253 is close enough that we can observe it in remarkable detail with MUSE, yet far enough that we can still see the entire galaxy in a single field of view," said astronomer Enrico Congiu, a fellow at the European Southern Observatory in Santiago, and lead author of research being published in the journal Astronomy & Astrophysics.
"That's why NGC 253 is such a perfect target: it acts as a bridge between the ultra-detailed studies of the Milky Way and the large-scale studies of more distant galaxies. It gives us a rare opportunity to connect the small-scale physics with the big-picture view."
Sculptor is about 11 million light-years from Earth, making it one of the closest big galaxies to the Milky Way. A light-year is the distance light travels in a year, 9.5 trillion km.
Like the Milky Way, it is a barred spiral galaxy, meaning it has an elongated structure extending from its nucleus, with spiral arms extending from the ends of the bar. Its diameter of about 88,000 light-years is similar to the Milky Way's, as is its total mass. One major difference is Sculptor's rate of new star formation, estimated to be two to three times greater than that of the Milky Way.
Nearly 30 per cent of this star formation is happening near the galaxy's nucleus in what is called a starburst region, as revealed in colourful emissions shown in the new image.
The observations have given information on a wide range of properties such as the motion, age and chemical composition of stars and the movement of interstellar gas, an important component of any galaxy.
"Since the light from stars is typically bluer if the stars are young or redder if the stars are old, having thousands of colours lets us learn a lot about what stars and populations of stars exist in the galaxy," said astronomer Kathryn Kreckel of Heidelberg University in Germany, a study co-author.
"Similarly for the gas, it glows in specific bright emission lines at very specific colours, and tells us about the different elements that exist in the gas, and what is causing it to glow," Kreckel said.
The initial research being published from the observations involves planetary nebulae, which are luminous clouds of gas and dust expelled by certain dying stars. Despite their name, they have nothing to do with planets. These nebulae can help astronomers measure the precise distances of faraway galaxies.
The researchers marveled at the scientific and aesthetic value of the new view of Sculptor.
"I personally find these images amazing," Congiu said.
"What amazes me the most is that every time I look at them, I notice something new - another nebula, a splash of unexpected colour or some subtle structure that hints at the incredible physics behind it all."
The Sculptor galaxy is similar in many respects to our Milky Way. It is about the same size and mass, with a similar spiral structure. But while it is impossible to get a full view of the Milky Way from the vantage point of Earth because we are inside the galaxy, Sculptor is perfectly positioned for a good look.
Astronomers have done just that, releasing an ultra-detailed image of the Sculptor galaxy on Wednesday obtained with 50 hours of observations using one of the world's biggest telescopes, the European Southern Observatory's Chile-based Very Large Telescope.
The image shows Sculptor, also called NGC 253, in around 4000 different colours, each corresponding to a specific wavelength in the optical spectrum.
Because various galactic components emit light differently across the spectrum, the observations are providing information at unprecedented detail on the inner workings of an entire galaxy, from star formation to the motion of interstellar gas on large scales. Conventional images in astronomy offer only a handful of colours, providing less information.
The researchers used the telescope's Multi Unit Spectroscopic Explorer, or MUSE, instrument.
"NGC 253 is close enough that we can observe it in remarkable detail with MUSE, yet far enough that we can still see the entire galaxy in a single field of view," said astronomer Enrico Congiu, a fellow at the European Southern Observatory in Santiago, and lead author of research being published in the journal Astronomy & Astrophysics.
"That's why NGC 253 is such a perfect target: it acts as a bridge between the ultra-detailed studies of the Milky Way and the large-scale studies of more distant galaxies. It gives us a rare opportunity to connect the small-scale physics with the big-picture view."
Sculptor is about 11 million light-years from Earth, making it one of the closest big galaxies to the Milky Way. A light-year is the distance light travels in a year, 9.5 trillion km.
Like the Milky Way, it is a barred spiral galaxy, meaning it has an elongated structure extending from its nucleus, with spiral arms extending from the ends of the bar. Its diameter of about 88,000 light-years is similar to the Milky Way's, as is its total mass. One major difference is Sculptor's rate of new star formation, estimated to be two to three times greater than that of the Milky Way.
Nearly 30 per cent of this star formation is happening near the galaxy's nucleus in what is called a starburst region, as revealed in colourful emissions shown in the new image.
The observations have given information on a wide range of properties such as the motion, age and chemical composition of stars and the movement of interstellar gas, an important component of any galaxy.
"Since the light from stars is typically bluer if the stars are young or redder if the stars are old, having thousands of colours lets us learn a lot about what stars and populations of stars exist in the galaxy," said astronomer Kathryn Kreckel of Heidelberg University in Germany, a study co-author.
"Similarly for the gas, it glows in specific bright emission lines at very specific colours, and tells us about the different elements that exist in the gas, and what is causing it to glow," Kreckel said.
The initial research being published from the observations involves planetary nebulae, which are luminous clouds of gas and dust expelled by certain dying stars. Despite their name, they have nothing to do with planets. These nebulae can help astronomers measure the precise distances of faraway galaxies.
The researchers marveled at the scientific and aesthetic value of the new view of Sculptor.
"I personally find these images amazing," Congiu said.
"What amazes me the most is that every time I look at them, I notice something new - another nebula, a splash of unexpected colour or some subtle structure that hints at the incredible physics behind it all."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Groundbreaking Vera Rubin Observatory reveals first images
Groundbreaking Vera Rubin Observatory reveals first images

News.com.au

time5 hours ago

  • News.com.au

Groundbreaking Vera Rubin Observatory reveals first images

The team behind the long-awaited Vera Rubin Observatory in Chile published their first images on Monday, revealing breathtaking views of star-forming regions as well as distant galaxies. More than two decades in the making, the giant US-funded telescope sits perched at the summit of Cerro Pachon in central Chile, where dark skies and dry air provide ideal conditions for observing the cosmos. One of the debut images is a composite of 678 exposures taken over just seven hours, capturing the Trifid Nebula and the Lagoon Nebula -- both several thousand light-years from Earth -- glowing in vivid pinks against orange-red backdrops. The image reveals these stellar nurseries within our Milky Way in unprecedented detail, with previously faint or invisible features now clearly visible. Another image offers a sweeping view of the Virgo Cluster of galaxies. The team also released a video dubbed the "cosmic treasure chest," which begins with a close-up of two galaxies before zooming out to reveal approximately 10 million more. "The Rubin Observatory is an investment in our future, which will lay down a cornerstone of knowledge today on which our children will proudly build tomorrow," said Michael Kratsios, director of the White House Office of Science and Technology Policy. Equipped with an advanced 8.4-meter telescope and the largest digital camera ever built, the Rubin Observatory is supported by a powerful data-processing system. Later this year, it will begin its flagship project, the Legacy Survey of Space and Time (LSST). Over the next decade, it will scan the night sky nightly, capturing even the subtlest visible changes with unmatched precision. The observatory is named after pioneering American astronomer Vera C. Rubin, whose research provided the first conclusive evidence for the existence of dark matter -- a mysterious substance that does not emit light but exerts gravitational influence on galaxies. Dark energy refers to the equally mysterious and immensely powerful force believed to be driving the accelerating expansion of the universe. Together, dark matter and dark energy are thought to make up 95 percent of the cosmos, yet their true nature remains unknown. The observatory, a joint initiative of the US National Science Foundation and Department of Energy, has also been hailed as one of the most powerful tools ever built for tracking asteroids. In just 10 hours of observations, the Rubin Observatory discovered 2,104 previously undetected asteroids in our solar system, including seven near-Earth objects -- all of which pose no threat. For comparison, all other ground- and space-based observatories combined discover about 20,000 new asteroids per year. Rubin is also set to be the most effective observatory at spotting interstellar objects passing through the solar system. More images from the observatory are expected to be released later Monday morning.

First images from Vera C. Rubin Observatory released, giving a taste of what's to come
First images from Vera C. Rubin Observatory released, giving a taste of what's to come

ABC News

time5 hours ago

  • ABC News

First images from Vera C. Rubin Observatory released, giving a taste of what's to come

A stunning nebula and a sky dotted full of bright stars and dancing galaxies are in the first set of three images released by the Vera C. Rubin Observatory. The ground-based telescope, which uses the world's largest digital camera, promises to revolutionise entire fields of astronomy with its wide angle and powerful lens. The images are a taster of what is expected to be unveiled at 1AM AEST Tuesday morning in a live stream that will also include ultra-high definition video. According to astronomers, even these first previews are unlike anything they've ever seen before. Rachel Webster, an astrophysicist at the University of Mebourne, said she was stunned by the vast scale of each picture. One of Rubin's early pictures is of the Lagoon and Trifid nebulas, two huge regions of interstellar gas some 5,200 and 9,000 light-years away in the constellation of Sagittarius. The image is a composite built from 678 different pictures, captured over a seven-hour period. Jonti Horner, astrophysicist at the University of Southern Queensland, said the nebulas are one of the "jewels of the night sky" that amateur astronomers often turn their telescopes towards. Professor Horner said that the detail was "breathtaking". While other big space telescopes can achieve this level of detail, Professor Webster said they can't do it with the wide angle Rubin enjoys. "Here, we've got the depth of a big telescope with a very big field of view, and that's very exciting." Professor Webster said that the colours can tell astronomers about the physical processes happening in the nebulas. Pink, for instance, indicates a lot of hydrogen. "There's lots of stars in the pink areas and those are hot young stars," Professor Webster said. But what sets Rubin's imagery apart is the orange regions around the nebulas. Professor Webster said the orange likely indicates dust — but she's not seen an image like it before. "This is not surprising, but you don't normally see this large scale." The other two pictures Rubin has released both look beyond our galaxy to the Virgo Cluster. This is a group of galaxies 55 million light-years away in the constellation of Virgo. The entire group spans about 8 degrees across the sky, making it too wide for most high-power telescopes to snap in one image. But, as Swinburne University astrophysicist Tania Barone pointed out, Rubin is designed to see the whole thing in detail. Part of this important context is the way the galaxies interact with one another, connected by faintly glowing strings of stars. "Often when you look at images that don't go quite as deep, all the galaxies look isolated," Dr Barone said. "It's only when you get this really beautiful deep imaging that you see the trails and connections between them and the way that they're merging." One Rubin image shows three merging galaxies in a corner, with clear connections in between each. "We're seeing this cosmic dance in motion as they intertwine and merge," Dr Barone said. While the bright stars with their telltale points and the swirling galaxies might draw the most attention, it's the indistinct, pale smudges that Dr Webster is excited by. Some of these smudges might be faint Milky Way objects, while others could be unusual galaxies without bright, massive centres. "For a long time people have speculated on crouching giants, which are amorphous collections of stars that don't have big nuclei in them," Dr Webster said. There are also features in the images she can't immediately identify — such as a cluster of three galaxies to the left of the image. "I just look at it and I think: what on Earth is going on there?" Dr Webster said. "I've never seen a galaxy that looks like that before." The official unveiling happens at 1am (AEST) this Tuesday, June 24. If you are keen, you can watch the unveiling live on the telescope's website or rug up and go to a watch party in Melbourne, Sydney or Perth. The Rubin Observatory, which is run by the US but based in Chile, will take photographs of the night sky every few seconds for the next 10 years. With its 8.4 metre mirror and 3,000kg camera, the observatory will be able to document the entire night sky every few days. This means it will be able to spot very subtle changes happening quickly — opening up new fields of research into astrophysics and dark matter. "We're going to get these really nice, beautiful, clear images of the whole southern sky," Dr Barone said. But it will also be useful for finding things much closer, like asteroids and Solar System objects. The observatory is set to start its 10-year survey later this year, but astronomers are expecting exciting results from it straightaway. "Within the first 12 months, there'll be some super results," Professor Webster said. They're also not expecting its job to be done after its initial decade. "If I'm still talking to journalists in 20 years time, we'll still be talking about Vera Rubin," Professor Horner said. "It'll still be delivering new results, even then."

'Game changer' diabetes pill a step closer after trials
'Game changer' diabetes pill a step closer after trials

The Advertiser

timea day ago

  • The Advertiser

'Game changer' diabetes pill a step closer after trials

Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store